News posted by www.newsinfoline.com
Orchid Chemicals & Pharmaceuticals Ltd said on Wednesday it has signed an out-licensing and distribution deal with U.S.-based Alvogen for marketing the Indian company's eight oral non-antibiotic formulations in U.S.Under the terms of the agreement, Alvogen would pay certain dossier license fees to Orchid and the companies would share profits from these products, it said in a statement.The combined market size of these products in the U.S. is about $8 billion, it said.(Reporting by Kaustubh Kulkarni; Editing by Ramya Venugopal)(For more business news on Reuters Money visit http://www.reutersmoney.in)
News posted by www.newsinfoline.com
Click here to read more news from www.newsinfoline.com
Please follow our blogs
newsinfolinephotogallery
prabugallery
newsinfolinephotogallery1
photogallery1
No comments:
Post a Comment